21-hydroxylase deficiency differential diagnosis: Difference between revisions

Jump to navigation Jump to search
Line 21: Line 21:
|[[21-hydroxylase deficiency|Classic type of 21-hydroxylase deficiency]]
|[[21-hydroxylase deficiency|Classic type of 21-hydroxylase deficiency]]
|
|
* [[17-hydroxyprogestrone]]
* [[17-Hydroxyprogesterone|17-hydroxyprogesterone]]
* [[Progesterone]]
* [[Progesterone]]
* [[Androstenedione]]
* [[Androstenedione]]
Line 28: Line 28:
* [[Aldosterone]]
* [[Aldosterone]]
* [[Corticosterone]] (salt-wasting)
* [[Corticosterone]] (salt-wasting)
* [[Cortisol]] (simple virilizing)
* [[Cortisol]] (simple [[virilizing]])
|
|
* [[Ambigus genitalia]] in female
* [[Ambiguous genitalia]] in female
* [[Virilization]] in female
* [[Virilization]] in female
* Salt-wasting
* Salt-wasting
Line 37: Line 37:
|[[11β-hydroxylase deficiency|11-β hydroxylase deficiency]]
|[[11β-hydroxylase deficiency|11-β hydroxylase deficiency]]
|
|
* DOC
* [[Deoxycorticosterone]]
* 11-Deoxy-cortisol
* 11-Deoxy-[[cortisol]]
* [[17-hydroxyprogestrone]], mild elevation
* [[17-Hydroxyprogesterone|17-hydroxyprogesterone]], mild elevation
|
|
* [[Cortisol]]
* [[Cortisol]]
Line 45: Line 45:
* [[Aldosterone]]
* [[Aldosterone]]
|
|
* Ambigus genitalia in female
* [[Ambiguous genitalia]] in female
* Hypertension and hypokalemia
* [[Hypertension]] and [[hypokalemia]]
*Virilization
* [[Virilization]]
|-
|-
|[[Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency|17-α hydroxylase deficiency]]
|[[17 alpha-hydroxylase deficiency|17-α hydroxylase deficiency]]
|
|
* DOC
* [[Deoxycorticosterone]]
* Corticosterone
* [[Corticosterone]]
* Progesterone
* [[Progesterone]]
|
|
* Cortisol
* [[Cortisol]]
* Aldosterone
* [[Aldosterone]]
|
|
* Ambigus genitalia in male
* [[Ambiguous genitalia]] in male
* Hypertension
* [[Hypertension]]


* Primary amenorrhea
* [[Primary amenorrhea]]


* Absence of secondary sexual characteristics
* Absence of [[secondary sexual characteristics]]


* Minimal body hair
* Minimal [[body hair]]
|-
|-
|3β-Hydroxysteroid Dehydrogenase  
|3β-Hydroxysteroid Dehydrogenase  
|
|
* DHEA
* [[Dehydroepiandrosterone]]
* 17-OH pregneno-lone
* [[17-hydroxypregnenolone]]
* Pregnenolone
* [[Pregnenolone]]
|
|
* Cortisol
* [[Cortisol]]
* Aldosterone
* [[Aldosterone]]
|
|
* Vomiting, volume depletion, hyponatremia, and hyperkalemia
* [[Vomiting]], [[volume depletion]], [[hyponatremia]], and [[hyperkalemia]]
* 46-XY infants often show undervirilization, due to a block in testosterone synthesis
* 46-XY infants often show [[undervirilization]], due to a block in [[testosterone]] synthesis
|-
|-
|Gestational hyperandrogenism
|Gestational [[hyperandrogenism]]
|
|
* Maternal serum androgen concentrations (usually testosterone and androstenedione) are high  
* Maternal serum [[androgen]] concentrations (usually [[testosterone]] and [[androstenedione]]) are high  
* If virilization is caused by exogenous hormone administration, the values may be low because the offending hormone is usually a synthetic steroid not measured in assays for testosterone or other androgens
* If [[virilization]] is caused by exogenous hormone administration, the values may be low because the offending hormone is usually a synthetic [[steroid]] not measured in assays for [[testosterone]] or other [[androgens]]
|
|
|
|
* Androgen excess sign and symptoms in mother
* [[Androgen]] excess sign and symptoms in mother
* History of androgen containing medication  consumption during pregnancy in mother
* History of [[androgen]] containing [[medication]] consumption during [[pregnancy]] in mother
* Virilization in a 46,XX individual with normal female internal anatomy
* [[Virilization]] in a 46,XX individual with normal female internal anatomy
* Causes include maternal luteoma or theca-lutein cysts, and placental aromatase enzyme deficiency
* Causes include maternal [[luteoma]] or theca-[[lutein]] [[cysts]], and [[placental]] [[aromatase]] enzyme deficiency
|}
|}


Line 101: Line 101:
|Non-classic type of 21-hydroxylase deficiency
|Non-classic type of 21-hydroxylase deficiency
|Increased:
|Increased:
* 17-OHP
* [[17-Hydroxyprogesterone|17-hydroxyprogesterone]]
* Exaggerated androstene-dione, DHEA, and 17-OHP
* Exaggerated [[Androstenedione]], [[DHEA]], and [[17-Hydroxyprogesterone|17-hydroxyprogesterone]]
response to ACTH  
response to [[ACTH]]
|
|
* Low testosterone levels
* Low [[testosterone]] levels
|
|
* No symptoms in infancy and male
* No symptoms in infancy and male


* Virilization in females
* [[Virilization]] in females
|-
|-
|[[Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency|11-β hydroxylase deficiency]]
|[[11β-hydroxylase deficiency|11-β hydroxylase deficiency]]
|Increased:
|Increased:
* DOC
* DOC
* 11-Deoxy-
* 11-Deoxy-[[Cortisol]]
* cortisol
Decreased:
Decreased:
* Cortisol
* [[Cortisol]]
* Corticosterone
* [[Corticosterone]]
* Aldosterone  
* [[Aldosterone]]
|
|
* Low testosterone levels
* Low [[testosterone]] levels
|
|
* Hypertension and hypokalemia
* [[Hypertension]] and [[hypokalemia]]
* Virilization
* [[Virilization]]
|-
|-
|3β-Hydroxysteroid Dehydrogenase  
|3β-Hydroxysteroid Dehydrogenase  
|Increased:
|Increased:
* DHEA
* [[DHEA]]
* 17-OH pregneno-lone
* [[17-hydroxypregnenolone]]
* Pregnenolone
* [[Pregnenolone]]
Decreased:
Decreased:
* Cortisol
* [[Cortisol]]
* Aldosterone
* [[Aldosterone]]
|
|
* Low testosterone levels
* Low [[testosterone]] levels
|
|
* Salt-wasting adrenal crises in infancy
* Salt-wasting adrenal crises in infancy
* Mild virilization of genetically female infants  
* Mild [[virilization]] of genetically female infants  
* Undervirilization of genetically male infants, making it the only form of CAH which can cause ambiguous genitalia in both genetic sexes.  
* Undervirilization of genetically male infants, making it the only form of [[CAH]] which can cause [[ambiguous genitalia]] in both genetic sexes.  
|-
|-
|Polycystic ovary syndrome  
|[[Polycystic ovary syndrome ]]
|
|
* High DHEAS and androstenedione levels
* High [[DHEAS]] and [[androstenedione]] levels
|
|
* Low testosterone levels
* Low [[testosterone]] levels
|
|
* Polycystic ovaries in sonography
* Polycystic ovaries in sonography
* Obesity  
* [[Obesity]]
* PCOS is the most common cause of hirsutism in women
* [[PCOS]] is the most common cause of [[hirsutism]] in women
* No evidence another diagnosis  
* No evidence another diagnosis  
|-
|-
|Adrenal tumors
|[[Adrenal tumors]]
|
|
* Variable levels depends on tumor type
* Variable levels depends on [[tumor]] type
|
|
* Low testosterone level
* Low [[testosterone]] level
|
|
* Older age
* Older age
* Rapidly progressive symptoms
* Rapidly progressive symptoms
|-
|-
|Ovarian virilizing tumor
|Ovarian [[virilizing]] tumor
|
|
* Variable levels depends on tumor type
* Variable levels depends on [[tumor]] type
|
|
* Testosterone is high  
* [[Testosterone]] is high  
|
|
* Older age
* Older age
* Rapidly progressive symptoms
* Rapidly progressive symptoms
|-
|-
|Cushing's syndrome
|[[Cushing's syndrome]]
|
|
* Increase cortisol & metabolites
* Increase [[cortisol]] & metabolites
* Variable other steroids
* Variable other [[steroids]]
|
|
* Variable mineralocorticoid excess
* Variable [[mineralocorticoid]] excess
|
|
* Cushingoid features
* Cushingoid features
|-
|-
|Hyperprolactinemia
|[[Hyperprolactinemia]]
|
|
* Normal levels of most of steroids
* Normal levels of most of [[steroids]]
|
|
* Increased prolactin
* Increased [[prolactin]]
|
|
* Infertility, galactorrea  
* [[Infertility]], [[galactorrea]]
|}
|}


== References ==
== References ==
{{Reflist|2}}
{{Reflist|2}}

Revision as of 14:09, 1 August 2017


Congenital adrenal hyperplasia main page

21-hydroxylase deficiency Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating 21-Hydroxylase Deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

21-hydroxylase deficiency differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of 21-hydroxylase deficiency differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on 21-hydroxylase deficiency differential diagnosis

CDC on 21-hydroxylase deficiency differential diagnosis

21-hydroxylase deficiency differential diagnosis in the news

Blogs on 21-hydroxylase deficiency differential diagnosis

Directions to Hospitals Treating 21-Hydroxylase Deficiency

Risk calculators and risk factors for 21-hydroxylase deficiency differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Mehrian Jafarizade, M.D [2]

Overview

21-hydroxylase deficiency must be differentiated from 11-β hydroxylase deficiency, 17-α hydroxylase deficiency, androgen insensitivity syndrome, 3β-Hydroxysteroid Dehydrogenase, polycystic ovarian syndrome, hyperprolactinemia, cushing syndrome, and adrenal tumor.

Differentiating congenital adrenal hyperplasia due to 21-hydroxylase deficiency from other diseases

Congenital adrenal hyperplasia due to 21-hydroxylase deficiency classic type must be differentiated from diseases that cause ambiguous genitalia:[1][2]

Disease name Laboratory tests Important clinical findings
Increased Decreased
Classic type of 21-hydroxylase deficiency
11-β hydroxylase deficiency
17-α hydroxylase deficiency
3β-Hydroxysteroid Dehydrogenase
Gestational hyperandrogenism

21-hydroxylase deficiency Non-classic type must be differentiated from diseases that cause virilization and hirsutism in female:[3][2][4]

Disease name Steroid status Other laboratory Important clinical findings
Non-classic type of 21-hydroxylase deficiency Increased:

response to ACTH

  • No symptoms in infancy and male
11-β hydroxylase deficiency Increased:

Decreased:

3β-Hydroxysteroid Dehydrogenase Increased:

Decreased:

  • Salt-wasting adrenal crises in infancy
  • Mild virilization of genetically female infants
  • Undervirilization of genetically male infants, making it the only form of CAH which can cause ambiguous genitalia in both genetic sexes.
Polycystic ovary syndrome
  • Polycystic ovaries in sonography
  • Obesity
  • PCOS is the most common cause of hirsutism in women
  • No evidence another diagnosis
Adrenal tumors
  • Variable levels depends on tumor type
  • Older age
  • Rapidly progressive symptoms
Ovarian virilizing tumor
  • Variable levels depends on tumor type
  • Older age
  • Rapidly progressive symptoms
Cushing's syndrome
  • Cushingoid features
Hyperprolactinemia

References

  1. Hughes IA, Nihoul-Fékété C, Thomas B, Cohen-Kettenis PT (2007). "Consequences of the ESPE/LWPES guidelines for diagnosis and treatment of disorders of sex development". Best Pract. Res. Clin. Endocrinol. Metab. 21 (3): 351–65. doi:10.1016/j.beem.2007.06.003. PMID 17875484.
  2. 2.0 2.1 White PC, Speiser PW (2000). "Congenital adrenal hyperplasia due to 21-hydroxylase deficiency". Endocr. Rev. 21 (3): 245–91. doi:10.1210/edrv.21.3.0398. PMID 10857554.
  3. Hohl A, Ronsoni MF, Oliveira M (2014). "Hirsutism: diagnosis and treatment". Arq Bras Endocrinol Metabol. 58 (2): 97–107. PMID 24830586. Vancouver style error: initials (help)
  4. Melmed, Shlomo (2016). Williams textbook of endocrinology. Philadelphia, PA: Elsevier. ISBN 978-0323297387.=